scholarly journals The comparative efficacy and safety of anti-CD20 monoclonal antibodies for relapsing-remitting multiple sclerosis: A network meta-analysis

2021 ◽  
Vol 11 ◽  
pp. 103-111
Author(s):  
Mohammad Z.I. Asha ◽  
Yousef Al-Asaad ◽  
Sundos F.H. Khalil
Sign in / Sign up

Export Citation Format

Share Document